Sabrina Coluzzi

884 total citations
7 papers, 584 citations indexed

About

Sabrina Coluzzi is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Sabrina Coluzzi has authored 7 papers receiving a total of 584 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Hematology, 3 papers in Molecular Biology and 2 papers in Genetics. Recurrent topics in Sabrina Coluzzi's work include Eosinophilic Disorders and Syndromes (2 papers), Thyroid Cancer Diagnosis and Treatment (2 papers) and Chronic Myeloid Leukemia Treatments (2 papers). Sabrina Coluzzi is often cited by papers focused on Eosinophilic Disorders and Syndromes (2 papers), Thyroid Cancer Diagnosis and Treatment (2 papers) and Chronic Myeloid Leukemia Treatments (2 papers). Sabrina Coluzzi collaborates with scholars based in Italy, United States and United Kingdom. Sabrina Coluzzi's co-authors include Giancarlo Troncone, Alfredo Fusco, C-G Liu, Fabio Petrocca, Giovanni Tallini, Vincenza Leone, Pierlorenzo Pallante, Stefano Volinia, Aldo Scarpa and Chiara Colato and has published in prestigious journals such as Blood, Oncogene and Endocrine Related Cancer.

In The Last Decade

Sabrina Coluzzi

7 papers receiving 574 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sabrina Coluzzi Italy	7	275	267	144	127	111	7	584
Mark Dowar Canada	9	214 0.8×	146 0.5×	104 0.7×	81 0.6×	144 1.3×	12	460
Roelof Koster Netherlands	11	351 1.3×	118 0.4×	39 0.3×	79 0.6×	210 1.9×	23	672
Markus Mayrhofer Sweden	12	153 0.6×	181 0.7×	108 0.8×	47 0.4×	101 0.9×	21	506
Adrienne Lawton United States	10	186 0.7×	193 0.7×	79 0.5×	29 0.2×	150 1.4×	11	512
Manuela Puopolo Italy	9	272 1.0×	120 0.4×	48 0.3×	70 0.6×	164 1.5×	11	521
Aysim Yilmaz Switzerland	5	301 1.1×	131 0.5×	81 0.6×	37 0.3×	174 1.6×	7	556
P. Dieringer United States	7	299 1.1×	76 0.3×	54 0.4×	150 1.2×	203 1.8×	10	501
Remedios Castelló Spain	14	161 0.6×	159 0.6×	56 0.4×	110 0.9×	58 0.5×	14	638
M Oestreicher Switzerland	7	121 0.4×	80 0.3×	82 0.6×	90 0.7×	60 0.5×	8	357
F Desangles France	9	339 1.2×	106 0.4×	36 0.3×	206 1.6×	77 0.7×	18	552

Countries citing papers authored by Sabrina Coluzzi

Since Specialization

Citations

This map shows the geographic impact of Sabrina Coluzzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sabrina Coluzzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sabrina Coluzzi more than expected).

Fields of papers citing papers by Sabrina Coluzzi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sabrina Coluzzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sabrina Coluzzi. The network helps show where Sabrina Coluzzi may publish in the future.

Co-authorship network of co-authors of Sabrina Coluzzi

This figure shows the co-authorship network connecting the top 25 collaborators of Sabrina Coluzzi. A scholar is included among the top collaborators of Sabrina Coluzzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sabrina Coluzzi. Sabrina Coluzzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Coluzzi, Sabrina, et al.. (2017). Expression of some ATP-binding cassette transporters in acute myeloid leukemia. Hematology Reports. 9(4). 7406–7406. 24 indexed citations

2.

Olivieri, Attilio, Michele Cimminiello, Paolo Corradini, et al.. (2013). Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD. Blood. 122(25). 4111–4118. 67 indexed citations

3.

Attolico, Immacolata, Vincenzo Pavone, Angelo Ostuni, et al.. (2011). Plerixafor Added to Chemotherapy Plus G-CSF Is Safe and Allows Adequate PBSC Collection in Predicted Poor Mobilizer Patients with Multiple Myeloma or Lymphoma. Biology of Blood and Marrow Transplantation. 18(2). 241–249. 47 indexed citations

4.

Olivieri, Jacopo, et al.. (2011). Tirosin Kinase Inhibitors in Chronic Graft versus Host Disease: From Bench to Bedside. The Scientific World JOURNAL. 11. 1908–1931. 21 indexed citations

5.

Vitagliano, Donata, Valentina De Falco, Anna Tamburrino, et al.. (2010). The tyrosine kinase inhibitor ZD6474 blocks proliferation of RET mutant medullary thyroid carcinoma cells. Endocrine Related Cancer. 18(1). 1–11. 55 indexed citations

6.

Visone, Rosa, Pierlorenzo Pallante, Andrea Vecchione, et al.. (2007). Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. Oncogene. 26(54). 7590–7595. 312 indexed citations

7.

Vitagliano, Donata, Giuseppe Portella, Giancarlo Troncone, et al.. (2006). Thyroid targeting of the N-ras(Gln61Lys) oncogene in transgenic mice results in follicular tumors that progress to poorly differentiated carcinomas. Oncogene. 25(39). 5467–5474. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact